ORI — Orion Nutraceuticals Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Orion Nutraceuticals, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.386 | 0.903 | 2.52 | 0.28 | 0.316 |
| Operating Profit | -0.386 | -0.903 | -2.52 | -0.28 | -0.316 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.386 | -0.883 | -2.62 | -0.28 | -0.062 |
| Net Income After Taxes | -0.386 | -0.883 | -2.62 | -0.28 | -0.062 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.385 | -0.883 | -2.62 | -0.28 | -0.062 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.385 | -0.883 | -2.62 | -0.28 | -0.062 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.284 | -0.033 | -0.004 | -0.01 | -0.002 |